Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Vaccine against peanut allergy based on engineered Virus-Like-Particles displaying single major peanut allergens.

Storni F, Zeltins A, Balke I, Heath MD, Kramer MF, Skinner MA, Zha L, Roesti E, Engeroff P, Muri L, von Werdt D, Gruber T, Cragg M, Mlynarczyk M, Kündig TM, Vogel M, Bachmann MF.

J Allergy Clin Immunol. 2019 Dec 19. pii: S0091-6749(19)31709-9. doi: 10.1016/j.jaci.2019.12.007. [Epub ahead of print]

2.

Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing.

Zielen S, Kuna P, Aberer W, Lassmann S, Pfaar O, Klimek L, Wade A, Kluehr K, Raab J, Wessiepe D, Lee D, Kramer MF, Gunawardena K, Higenbottam T, Heath MD, Skinner MA, de Kam PJ.

World Allergy Organ J. 2019 Oct 25;12(11):100075. doi: 10.1016/j.waojou.2019.100075. eCollection 2019 Nov.

3.

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.

Cabral-Miranda G, Lim SM, Mohsen MO, Pobelov IV, Roesti ES, Heath MD, Skinner MA, Kramer MF, Martina BEE, Bachmann MF.

Vaccines (Basel). 2019 Jul 23;7(3). pii: E72. doi: 10.3390/vaccines7030072.

4.

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO, Heath MD, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, Stein JV, Riether C, Roesti E, Zha L, Engeroff P, El-Turabi A, Kundig TM, Vogel M, Skinner MA, Speiser DE, Knuth A, Kramer MF, Bachmann MF.

J Immunother Cancer. 2019 May 23;7(1):137. doi: 10.1186/s40425-019-0616-y.

5.

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO, Heath MD, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, Stein JV, Riether C, Roesti E, Zha L, Engeroff P, El-Turabi A, Kundig TM, Vogel M, Skinner MA, Speiser DE, Knuth A, Kramer MF, Bachmann MF.

J Immunother Cancer. 2019 Apr 26;7(1):114. doi: 10.1186/s40425-019-0587-z. Erratum in: J Immunother Cancer. 2019 May 23;7(1):137.

6.

Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season.

Mösges R, Breitrück NY, Allekotte S, Shah-Hosseini K, Dao VA, Zieglmayer P, Birkholz K, Hess M, Bastl M, Bastl K, Berger U, Kramer MF, Guethoff S.

World Allergy Organ J. 2019 Mar 8;12(2):100012. doi: 10.1016/j.waojou.2019.100012. eCollection 2019.

7.

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases.

Klimek L, Kündig T, Kramer MF, Guethoff S, Jensen-Jarolim E, Schmidt-Weber CB, Palomares O, Mohsen MO, Jakob T, Bachmann M.

Allergo J Int. 2018;27(8):245-255. doi: 10.1007/s40629-018-0074-y. Epub 2018 Jul 9. Review.

8.

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy.

Worm M, Higenbottam T, Pfaar O, Mösges R, Aberer W, Gunawardena K, Wessiepe D, Lee D, Kramer MF, Skinner M, Lees B, Zielen S.

Allergy. 2018 Sep;73(9):1812-1822. doi: 10.1111/all.13478. Epub 2018 Jun 19.

9.

Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.

Leuthard DS, Duda A, Freiberger SN, Weiss S, Dommann I, Fenini G, Contassot E, Kramer MF, Skinner MA, Kündig TM, Heath MD, Johansen P.

J Immunol. 2018 May 1;200(9):3151-3159. doi: 10.4049/jimmunol.1800035. Epub 2018 Mar 28.

10.

Aluminium (Al) speciation in serum and urine after subcutaneous venom immunotherapy with Al as adjuvant.

Michalke B, Kramer MF, Brehler R.

J Trace Elem Med Biol. 2018 Sep;49:178-183. doi: 10.1016/j.jtemb.2018.02.014. Epub 2018 Feb 21.

PMID:
29496416
11.

Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.

Cabral-Miranda G, Heath MD, Gomes AC, Mohsen MO, Montoya-Diaz E, Salman AM, Atcheson E, Skinner MA, Kramer MF, Reyes-Sandoval A, Bachmann MF.

Vaccines (Basel). 2017 Sep 27;5(4). pii: E32. doi: 10.3390/vaccines5040032.

12.

The grass pollen season 2015: a proof of concept multi-approach study in three different European cities.

Kmenta M, Bastl K, Berger U, Kramer MF, Heath MD, Pätsi S, Pessi AM, Saarto A, Werchan B, Werchan M, Zetter R, Bergmann KC.

World Allergy Organ J. 2017 Sep 12;10(1):31. doi: 10.1186/s40413-017-0163-2. eCollection 2017.

13.

Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis.

Pfaar O, Lang S, Pieper-Fürst U, Astvatsatourov A, Gerich F, Klimek L, Kramer MF, Reydelet Y, Shah-Hosseini K, Mösges R.

Allergy. 2018 Jan;73(1):187-195. doi: 10.1111/all.13240. Epub 2017 Sep 5.

14.

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.

Cabral-Miranda G, Heath MD, Mohsen MO, Gomes AC, Engeroff P, Flaxman A, Leoratti FMS, El-Turabi A, Reyes-Sandoval A, Skinner MA, Kramer MF, Bachmann MF.

Vaccines (Basel). 2017 May 2;5(2). pii: E10. doi: 10.3390/vaccines5020010.

15.

Clinical use of adjuvants in allergen-immunotherapy.

Klimek L, Schmidt-Weber CB, Kramer MF, Skinner MA, Heath MD.

Expert Rev Clin Immunol. 2017 Jun;13(6):599-610. doi: 10.1080/1744666X.2017.1292133. Epub 2017 Feb 23. Review.

PMID:
28162007
16.

Real-Life Study for the Diagnosis of House Dust Mite Allergy - The Value of Recombinant Allergen-Based IgE Serology.

Becker S, Schlederer T, Kramer MF, Haack M, Vrtala S, Resch Y, Lupinek C, Valenta R, Gröger M.

Int Arch Allergy Immunol. 2016;170(2):132-7. doi: 10.1159/000447694. Epub 2016 Aug 10.

17.

The grass pollen season 2014 in Vienna: A pilot study combining phenology, aerobiology and symptom data.

Kmenta M, Bastl K, Kramer MF, Hewings SJ, Mwange J, Zetter R, Berger U.

Sci Total Environ. 2016 Oct 1;566-567:1614-1620. doi: 10.1016/j.scitotenv.2016.06.059. Epub 2016 Jun 15.

PMID:
27317132
18.

Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys.

König K, Klemens C, Haack M, Nicoló MS, Becker S, Kramer MF, Gröger M.

Allergy Asthma Clin Immunol. 2016 Apr 27;12:19. doi: 10.1186/s13223-016-0123-3. eCollection 2016.

19.

Analysis of aluminium in rat following administration of allergen immunotherapy using either aluminium or microcrystalline-tyrosine-based adjuvants.

McDougall SA, Heath MD, Kramer MF, Skinner MA.

Bioanalysis. 2016 Mar;8(6):547-56. doi: 10.4155/bio.16.10. Epub 2016 Feb 26.

20.

In vitro evidence for efficacy in food intolerance for the multispecies probiotic formulation Ecologic® Tolerance (Syngut™).

Besseling-van der Vaart I, Heath MD, Guagnini F, Kramer MF.

Benef Microbes. 2016 Feb;7(1):111-118. doi: 10.3920/BM2015.0051. Epub 2015 Nov 13.

PMID:
26565083
21.

Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis.

König K, Klemens C, Eder K, San Nicoló M, Becker S, Kramer MF, Gröger M.

Allergy Asthma Clin Immunol. 2015 Sep 22;11(1):26. doi: 10.1186/s13223-015-0093-x. eCollection 2015.

22.

Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa.

Becker S, Rasp J, Eder K, Berghaus A, Kramer MF, Gröger M.

Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1469-75. doi: 10.1007/s00405-015-3769-4. Epub 2015 Sep 5.

PMID:
26342925
23.

Aluminium in allergen-specific subcutaneous immunotherapy--a German perspective.

Kramer MF, Heath MD.

Vaccine. 2014 Jul 16;32(33):4140-8. doi: 10.1016/j.vaccine.2014.05.063. Epub 2014 Jun 2.

24.

Probiotics in the treatment of chronic rhinoconjunctivitis and chronic rhinosinusitis.

Kramer MF, Heath MD.

J Allergy (Cairo). 2014;2014:983635. doi: 10.1155/2014/983635. Epub 2014 Apr 28. Review.

25.

[Diagnosis and treatment of acute and chronic rhinosinusitis].

Stelter K, Kramer MF.

MMW Fortschr Med. 2013 Mar 28;155 Spec No 1(1):49-53; quiz 54. Review. German. No abstract available.

PMID:
24260920
26.

Correlation of three variables describing nasal patency (HD, MCA, NOSE score) in healthy subjects.

Braun T, Rich M, Kramer MF.

Braz J Otorhinolaryngol. 2013 May-Jun;79(3):354-8. doi: 10.5935/1808-8694.20130062. English, Portuguese.

27.

[Allergic rhinitis: burden of disease].

Kramer MF.

MMW Fortschr Med. 2013 Mar 21;155(5):57-60; quiz 61-2. Review. German. No abstract available.

PMID:
23654135
28.

IgE reactivity profiles among house dust mite allergic patients in Bavaria.

Becker S, Kramer MF, Havel M, Welz C, Markmann S, Gröger M.

Eur Arch Otorhinolaryngol. 2013 Nov;270(12):3177-82. doi: 10.1007/s00405-013-2516-y. Epub 2013 Apr 30.

PMID:
23632872
29.

Non-allergic, mastocytosis-associated rhinitis.

Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF.

Clin Exp Allergy. 2013 Apr;43(4):406-12. doi: 10.1111/cea.12053.

PMID:
23517036
30.

Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases.

Gröger M, Bernt A, Wolf M, Mack B, Pfrogner E, Becker S, Kramer MF.

Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2667-76. doi: 10.1007/s00405-013-2395-2. Epub 2013 Feb 22.

PMID:
23430080
31.

Effects of oxymetazoline nasal spray on the nasal cycle assessed by long-term rhinoflowmetry.

Braun T, Rich M, Berghaus A, Kramer MF.

Rhinology. 2012 Dec;50(4):370-5. doi: 10.4193/Rhino12.032.

PMID:
23181250
32.

Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome.

Gröger M, Klemens C, Wendt S, Becker S, Canis M, Havel M, Pfrogner E, Rasp G, Kramer MF.

Int Arch Allergy Immunol. 2012;159(2):171-8. doi: 10.1159/000336169. Epub 2012 May 31.

PMID:
22652688
33.

Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad.

Havel M, Ertl L, Braunschweig F, Markmann S, Leunig A, Gamarra F, Kramer MF.

Eur Arch Otorhinolaryngol. 2013 Feb;270(2):571-8. doi: 10.1007/s00405-012-2048-x. Epub 2012 May 18.

PMID:
22610013
34.

Olfactory dysfunction in seasonal and perennial allergic rhinitis.

Becker S, Pflugbeil C, Gröger M, Canis M, Ledderose GJ, Kramer MF.

Acta Otolaryngol. 2012 Jul;132(7):763-8. doi: 10.3109/00016489.2012.656764. Epub 2012 Apr 12.

PMID:
22497546
35.

IgE reactivity patterns in patients with allergic rhinoconjunctivitis to ragweed and mugwort pollens.

Canis M, Becker S, Gröger M, Kramer MF.

Am J Rhinol Allergy. 2012 Jan-Feb;26(1):31-5. doi: 10.2500/ajra.2012.26.3698.

PMID:
22391077
36.

Solitary chemosensory cells in the respiratory and vomeronasal epithelium of the human nose: a pilot study.

Braun T, Mack B, Kramer MF.

Rhinology. 2011 Dec;49(5):507-12. doi: 10.4193/Rhino11.121.

PMID:
22125779
37.

Tropomyosin sensitization in house dust mite allergic patients.

Becker S, Gröger M, Canis M, Pfrogner E, Kramer MF.

Eur Arch Otorhinolaryngol. 2012 Apr;269(4):1291-6. doi: 10.1007/s00405-011-1826-1. Epub 2011 Nov 12.

PMID:
22081096
38.

Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia.

Kramer MF, Jurak I, Pesola JM, Boissel S, Knipe DM, Coen DM.

Virology. 2011 Sep 1;417(2):239-47. doi: 10.1016/j.virol.2011.06.027. Epub 2011 Jul 23.

39.

Stem-loop RT-qPCR for miRNAs.

Kramer MF.

Curr Protoc Mol Biol. 2011 Jul;Chapter 15:Unit 15.10. doi: 10.1002/0471142727.mb1510s95.

40.

Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens.

Canis M, Gröger M, Becker S, Klemens C, Kramer MF.

Am J Rhinol Allergy. 2011 Jan-Feb;25(1):36-9. doi: 10.2500/ajra.2011.25.3551.

PMID:
21711974
41.

Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study.

Braun T, Gürkov R, Kramer MF, Krause E.

Am J Otolaryngol. 2012 Jan-Feb;33(1):64-7. doi: 10.1016/j.amjoto.2011.01.004. Epub 2011 Mar 17.

PMID:
21419514
42.

[Food allergies: significance, interfaces, and prospects in otorhinolaryngology].

Dollner R, Kramer MF, Hauswald B.

Laryngorhinootologie. 2010 Oct;89(10):592-7. doi: 10.1055/s-0030-1265139. Epub 2010 Oct 14. Review. German.

PMID:
20949408
43.

Recombinant allergen profiles and health-related quality of life in seasonal allergic rhinitis.

Canis M, Gröger M, Becker S, Klemens C, Kramer MF.

Allergy Asthma Proc. 2010 May-Jun;31(3):219-26. doi: 10.2500/aap.2010.31.3333.

PMID:
20615322
44.

[Allergic rhinitis].

Kramer MF.

MMW Fortschr Med. 2010 May 20;152(20):31-2. German. No abstract available.

PMID:
20552877
45.

Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2.

Jurak I, Kramer MF, Mellor JC, van Lint AL, Roth FP, Knipe DM, Coen DM.

J Virol. 2010 May;84(9):4659-72. doi: 10.1128/JVI.02725-09. Epub 2010 Feb 24.

46.

Exhaled and nasal nitric oxide in laryngectomized patients.

Kramer MF, Olzowy B, Bihler A, de la Motte D, Nowak D, Jörres RA, Dressel H.

BMC Pulm Med. 2010 Jan 28;10:4. doi: 10.1186/1471-2466-10-4.

47.

Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis.

Powe DG, Groot Kormelink T, Sisson M, Blokhuis BJ, Kramer MF, Jones NS, Redegeld FA.

J Allergy Clin Immunol. 2010 Jan;125(1):139-45.e1-3. doi: 10.1016/j.jaci.2009.07.025. Epub 2009 Oct 8.

PMID:
19818484
48.

Coexistence of acute hearing loss with retinal artery occlusion and encephalopathy.

Wimmer E, Kramer MF, Bergmann C, Reiniger I, Harrèus U.

Am J Otolaryngol. 2009 May-Jun;30(3):145-9. doi: 10.1016/j.amjoto.2008.03.005. Epub 2008 Oct 1.

PMID:
19410116
49.

Enzymatic amplification of DNA by PCR: standard procedures and optimization.

Kramer MF, Coen DM.

Curr Protoc Cytom. 2006 Aug;Appendix 3:Appendix 3K. doi: 10.1002/0471142956.cya03ks37.

PMID:
18770830
50.

Diurnal variation of nasal nitric oxide levels in healthy subjects.

Dressel H, Bihler A, Jund F, de la Motte D, Nowak D, Jörres RA, Kramer MF.

J Investig Allergol Clin Immunol. 2008;18(4):316-7. No abstract available.

Supplemental Content

Loading ...
Support Center